Back to Search Start Over

New Myelofibrosis Research from University of Utah Discussed (A phase 1, open-label, dose-escalation study of selinexor plus ruxolitinib in patients with treatment-naive myelofibrosis)

Source :
Hematology Week. June 26, 2023, 3143
Publication Year :
2023

Abstract

2023 JUN 26 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Investigators publish new report on myelofibrosis. According to news reporting from Salt Lake City, Utah, [...]

Details

Language :
English
ISSN :
1543673X
Database :
Gale General OneFile
Journal :
Hematology Week
Publication Type :
News
Accession number :
edsgcl.754677605